Sudan
Sudan has suffered serious bouts of civil strife since independence in 1956, and although its health indicators are average for Africa, this masks significant disparities between rural and urban areas. Public healthcare is perceived to be of poor quality, and most people access care via the private sector, mainly out of pocket. Many parts of the country have no health provision. Infectious diseases constitute a high proportion of the disease burden, although non-communicable diseases are emerging quickly.
Imports of medicines constitute around 75% of the total market in Sudan, with the remainder manufactured locally.
The breakdown of the pharmaceutical market by disease type is as follows:
3 Musculoskeletal and Joint Diseases 8.9 %
9 OBS & Gynecological & UT disorders 4.1 %
11 Malignant Diseases & immunosuppressives 3.1 %
13 Ear Nose & Oropharynx (ENT) 1.7 %
The price of all these medicines, both imported and locally manufactured, is inflated by tariffs of 10%.
